Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 47



Campochiaro PA, Hafiz G, Mir TA, Scott AW, Zimmer-Galler I, Shah SM, Wenick AS, Brady CJ, Han I, He L, Channa R, Poon D, Meyerle C, Aronow MB, Sodhi A, Handa JT, Kherani S, Han Y, Sophie R, Wang G, Qian J.

Am J Ophthalmol. 2016 Oct;170:245-246. doi: 10.1016/j.ajo.2016.07.014. Epub 2016 Aug 22. No abstract available.


Preferred practice pattern in central serous chorioretinopathy.

Mehta PH, Meyerle C, Sivaprasad S, Boon C, Chhablani J.

Br J Ophthalmol. 2017 May;101(5):587-590. doi: 10.1136/bjophthalmol-2016-309247. Epub 2016 Aug 18.


Age-related macular degeneration in patients with uveitis.

Fox AR, Chew EY, Meyerle C, Vitale S, Ferris FL, Nussenblatt RB, Sen HN.

Br J Ophthalmol. 2016 May 6. pii: bjophthalmol-2016-308587. doi: 10.1136/bjophthalmol-2016-308587. [Epub ahead of print]


Pro-permeability Factors in Diabetic Macular Edema; the Diabetic Macular Edema Treated With Ozurdex Trial.

Campochiaro PA, Hafiz G, Mir TA, Scott AW, Zimmer-Galler I, Shah SM, Wenick AS, Brady CJ, Han I, He L, Channa R, Poon D, Meyerle C, Aronow MB, Sodhi A, Handa JT, Kherani S, Han Y, Sophie R, Wang G, Qian J.

Am J Ophthalmol. 2016 Aug;168:13-23. doi: 10.1016/j.ajo.2016.04.017. Epub 2016 Apr 27.


A Crossover Design for Comparative Efficacy: A 36-Week Randomized Trial of Bevacizumab and Ranibizumab for Diabetic Macular Edema.

Wiley HE, Thompson DJ, Bailey C, Chew EY, Cukras CA, Jaffe GJ, Lee RW, Loken EK, Meyerle CB, Wong W, Ferris FL 3rd.

Ophthalmology. 2016 Apr;123(4):841-9. doi: 10.1016/j.ophtha.2015.11.021. Epub 2016 Feb 10.


Changes in Retinal Nonperfusion Associated with Suppression of Vascular Endothelial Growth Factor in Retinal Vein Occlusion.

Mir TA, Kherani S, Hafiz G, Scott AW, Zimmer-Galler I, Wenick AS, Solomon S, Han I, Poon D, He L, Shah SM, Brady CJ, Meyerle C, Sodhi A, Linz MO, Sophie R, Campochiaro PA.

Ophthalmology. 2016 Mar;123(3):625-34.e1. doi: 10.1016/j.ophtha.2015.10.030. Epub 2015 Dec 19.


The Association of Statin Use with Cataract Progression and Cataract Surgery: The AREDS2 Report Number 8.

AREDS2 Research Group., Al-Holou SN, Tucker WR, Agrón E, Clemons TE, Sperduto RD, Ferris FL 3rd, Chew EY.

Ophthalmology. 2016 Apr;123(4):916-7. doi: 10.1016/j.ophtha.2015.10.040. Epub 2015 Dec 11. No abstract available.


Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema.

Wells JA, Glassman AR, Jampol LM, Aiello LP, Antoszyk AN, Baker CW, Bressler NM, Browning DJ, Connor CG, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW; Diabetic Retinopathy Clinical Research Network..

JAMA Ophthalmol. 2016 Feb;134(2):127-34. doi: 10.1001/jamaophthalmol.2015.4599. Erratum in: JAMA Ophthalmol. 2016 Apr;134(4):469.



Chhablani J, Kozak I, Pichi F, Chenworth M, Berrocal MH, Bedi R, Singh RP, Wu L, Meyerle C, Casella AM, Mansour A, Bashshur Z, Scorza A, Carrai P, Nucci P, Arevalo JF; King Khaled Eye Specialist Hospital International Collaborative Retina Study Group..

Retina. 2015 Dec;35(12):2489-97. doi: 10.1097/IAE.0000000000000655.


Effect of ranibizumab on high-speed indocyanine green angiography and minimum intensity projection optical coherence tomography findings in neovascular age-related macular degeneration.

Nicholson BP, Nigam D, Toy B, Stetson PF, Agrón E, Jacobs-El N, Cunningham D, Cukras C, Wong W, Wiley H, Chew E, Ferris F, Meyerle CB.

Retina. 2015 Jan;35(1):58-68. doi: 10.1097/IAE.0000000000000260.


In-depth analyses unveil the association and possible functional involvement of novel RAD51B polymorphisms in age-related macular degeneration.

Chu XK, Meyerle CB, Liang X, Chew EY, Chan CC, Tuo J.

Age (Dordr). 2014 Jun;36(3):9627. doi: 10.1007/s11357-014-9627-2. Epub 2014 Feb 14.


Subconjunctival Palomid 529 in the treatment of neovascular age-related macular degeneration.

Dalal M, Jacobs-El N, Nicholson B, Tuo J, Chew E, Chan CC, Nussenblatt R, Ferris F, Meyerle C.

Graefes Arch Clin Exp Ophthalmol. 2013 Dec;251(12):2705-9. doi: 10.1007/s00417-013-2375-7. Epub 2013 May 21.


Methods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2).

Danis RP, Domalpally A, Chew EY, Clemons TE, Armstrong J, SanGiovanni JP, Ferris FL 3rd; AREDS2 Study Group..

Invest Ophthalmol Vis Sci. 2013 Jul 8;54(7):4548-54. doi: 10.1167/iovs.13-11804.


Influence of TIMP3/SYN3 polymorphisms on the phenotypic presentation of age-related macular degeneration.

Ardeljan D, Meyerle CB, Agron E, Wang JJ, Mitchell P, Chew EY, Zhao J, Maminishkis A, Chan CC, Tuo J.

Eur J Hum Genet. 2013 Oct;21(10):1152-7. doi: 10.1038/ejhg.2013.14. Epub 2013 Feb 20.


Central serous chorioretinopathy: update on pathophysiology and treatment.

Nicholson B, Noble J, Forooghian F, Meyerle C.

Surv Ophthalmol. 2013 Mar-Apr;58(2):103-26. doi: 10.1016/j.survophthal.2012.07.004. Review.


Hypomethylation of the IL17RC promoter associates with age-related macular degeneration.

Wei L, Liu B, Tuo J, Shen D, Chen P, Li Z, Liu X, Ni J, Dagur P, Sen HN, Jawad S, Ling D, Park S, Chakrabarty S, Meyerle C, Agron E, Ferris FL 3rd, Chew EY, McCoy JP, Blum E, Francis PJ, Klein ML, Guymer RH, Baird PN, Chan CC, Nussenblatt RB.

Cell Rep. 2012 Nov 29;2(5):1151-8. doi: 10.1016/j.celrep.2012.10.013. Epub 2012 Nov 21.


Suggestive association between PLA2G12A single nucleotide polymorphism rs2285714 and response to anti-vascular endothelial growth factor therapy in patients with exudative age-related macular degeneration.

Wang VM, Rosen RB, Meyerle CB, Kurup SK, Ardeljan D, Agron E, Tai K, Pomykala M, Chew EY, Chan CC, Tuo J.

Mol Vis. 2012;18:2578-85. Epub 2012 Oct 20.


Oral minocycline for the treatment of diabetic macular edema (DME): results of a phase I/II clinical study.

Cukras CA, Petrou P, Chew EY, Meyerle CB, Wong WT.

Invest Ophthalmol Vis Sci. 2012 Jun 22;53(7):3865-74. doi: 10.1167/iovs.11-9413.


Treatment of nonneovascular idiopathic macular telangiectasia type 2 with intravitreal ranibizumab: results of a phase II clinical trial.

Toy BC, Koo E, Cukras C, Meyerle CB, Chew EY, Wong WT.

Retina. 2012 May;32(5):996-1006. doi: 10.1097/IAE.0b013e31824690a8.


Complement component C5a promotes expression of IL-22 and IL-17 from human T cells and its implication in age-related macular degeneration.

Liu B, Wei L, Meyerle C, Tuo J, Sen HN, Li Z, Chakrabarty S, Agron E, Chan CC, Klein ML, Chew E, Ferris F, Nussenblatt RB.

J Transl Med. 2011 Jul 15;9:1-12. doi: 10.1186/1479-5876-9-111.

Supplemental Content

Loading ...
Support Center